Trial Profile
Finding the Optimal Dose of Rivaroxaban in Hemodialysis Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Deep vein thrombosis
- Focus Pharmacodynamics; Pharmacokinetics
- 13 Jan 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 05 Mar 2014 New trial record